Uditi Handa

Ms. Uditi Handa


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2022 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
UHUditi Handa
Uditi Handa
Anuj MalikAnuj Malik
Anuj Malik
GKGuarve Kumar
Guarve Kumar
Superfluity drug delivery system (SFDDS) is an auspicious conception to obtain adequate oral bioavailability of poorly soluble drugs especially those drugs which are belongs to Biopharmaceutical Classification System II. The drug is in the form of high energy or otherwise swiftly dissolving form such that generated the drug in intraluminal concentrations above the saturation solubility which is liable for desired pharmacological response to the systemic circulation due to superfluity mechanism. The mechanism is based upon spring-parachute and hang-glider effect which involves the inhibition of nucleation with the help of precipitation inhibitors which will act as parachute and glider effect in superfluity formulations and the spring and hang will act as technology used to formulated the dosage form such as amorphous solid dispersion, co-crystals, supersaturated self-emulsifying drug-delivery system correlating to want the biological response is inadequate in the aqueous solubility of drug encountered with formulation development of new drug and existing drug as well as for the new formulation development of existing drug. The methods related to solubilization process are not necessarily improving the absorption in GIT i.e., the free fraction of drug molecules in the inter-micellar phase is limited at the time of dissolution process of the intestinal barrier. This review articles belongs to mechanism of superfluity strategy which overcomes many of the obstacles and limitations of solubilization methods especially very poorly water-soluble drug.

26 January 2024 in Current Pharmaceutical Analysis
Verified
Journal Article
Closed access
PDF file
UHUditi Handa
Uditi Handa
Anuj MalikAnuj Malik
Anuj Malik
KGKumar Guarve
Kumar Guarve
FJFatimah Jan
Fatimah Jan
KNKajal Nagpal
Kajal Nagpal
Background:: Previous studies of dextromethorphan hydrobromide basically worked on simultaneous research with other compounds. So, the development of a novel method using the isocratic elution mode is needed. Objective:: For the detection of dextromethorphan hydrobromide (DXM) in diverse matrices, a straightforward, accurate, and sensitive reversed-phase HPLC technique using a Waters 2487 Dual λ Absorbance detector has been designed and validated. Methods: In this experimental work, utilizing methanol/pH 3.0 potassium dihydrogen phosphate buffer (70:30, v/v) as the mobile phase, the separation was completed in 7 minutes on a C-18 HPLC column (4.6 cm length, 4.6 mm internal diameter; 5 μm particle size) utilizing an isocratic elution mode, flow rate of 1.0 mL/min, and UV-detection at 278 nm. Integration of the chromatography response was carried out using Empower 2.4 software Results:: With an R2 of 0.9987, the current approach showed high linearity for DXM in the 10- 60 ppm range (retention time 4.281 ± 0.505 min). For DXM Hbr, the limits of detection (LOD & LOQ) were 10.633 μg/mL and 32.221μg/mL, respectively. Samples remained stable in the presence of the matrices without any apparent influence. Conclusion:: The novel approach, which used a straightforward liquid/liquid extraction procedure with recovery ranging from 100 ± 10 % performed by two different analytes, was accurate. The precision within and between days was ≤ 2.0% (RSD). The technique was proven to be reliable and repeatable, and it can be utilized with pharmacological (active ingredients, syrups) and also for biological (blood) matrices which can be used in future research work for bioanalytical method development such as pharmacokinetics studies.

1 February 2025 in Anti-Infective Agents
Verified
Journal Article
Closed access
PDF file
KNKajal Nagpal
Kajal Nagpal
UHUditi Handa
Uditi Handa
ASAnjali Sharma
Anjali Sharma
DADeepshi Arora
Deepshi Arora
FJFatimah Jan
Fatimah Jan
Background: The use of commercial tinctures for the design of a formulation with improved anti-microbial activity in a polyherbal lozenge dosage form has not been described. Objective: This study aimed to develop and evaluate the antimicrobial activity of a novel polyherbal lozenge formulation containing Ashwagandha, Neem, and Tulsi tinctures in a single-dose administration. According to previous studies, each of these herbs could be used in herbal medicine to provide relief from infection owing to their antimicrobial activity, besides other properties, such as anticancer, antidiabetic, etc. Methods: The lozenges were prepared using the molding method using three concentrations (1, 3, and 5 % w/w) of commercialized herbal tinctures. Then, they were studied using different assays, including those designed to evaluate physical properties, stability, and antimicrobial activity. Results: B4, containing 5% w/w of each tincture, showed the highest antimicrobial activity compared with the other batches. This batch exhibited the highest value of bacterial inhibition (17.1 ± 0.07 mm), according to the agar well diffusion method, including Escherichia coli as a test microorganism. Hence, B4 was chosen for additional analyses, including physical properties and stability tests. The results followed Indian Pharmacopeia standards and ICH guidelines, respectively. The formulation was stable after 2 weeks, and no significant changes were observed in its physical properties or antimicrobial activity. Conclusion: This study shows that polyherbal lozenges have anti-microbial activity, with a disintegration period of 3.86 ± 0.07 minutes in the B4 batch.

1 February 2025 in Current Drug Therapy
Verified
Journal Article
Closed access
PDF file
APAnmol Popli
Anmol Popli
UHUditi Handa
Uditi Handa
KKKuldeep Kumar
Kuldeep Kumar
PSPrerna Sharma
Prerna Sharma
KGKumar Guarve
Kumar Guarve
IVInderjeet Verma
Inderjeet Verma
Background: Lozenges are one of the more well-liked and inventive oral confectionery products in the market. The lozenges also act as solid medications that are flavored, sweetened, and meant to be sucked into the mouth/pharynx or held over that cavity. Garlic contains anti-microbial agents which help to reduce the impact of cough and reduce it. Aims: The goal of the current research is to formulate and investigate herbal lozenges by using garlic tinctures with their antimicrobial action to cure the infection caused by microbes. Methods: Hard lozenges were prepared by Heating and congealing techniques and statistical analysis was done by using one sample chi-square test (IBM SPSS version 20). Results: Hard lozenges were formulated by using garlic tinctures with minimum excipients. According to ICH recommendations, stability experiments were conducted. According to the stability investigations, there were no major changes noticed during the period after the one-month stability test. The antimicrobial activity was studied under different time intervals after 8-72 hours. The inhibition zone value for the test sample was found to be 0.1-0.5 mm and for the standard sample was noticed from 0.5-0.8 mm, respectively. The statistical test outcome revealed, no remarkable difference shown between the prepared and the marketed formulation (p>0.05). Conclusion: From the present work, it was concluded that the prepared lozenges have similar result with minimum ingredients as compared to the marketed formulation (Tulsi-ginger lozenges). Hence, the formulation, testing, and antimicrobial activity for oral use in garlic lozenges were effective.

28 March 2024 in INDIAN DRUGS
Verified
Journal Article
Closed access
KNKajal Nagpal
Kajal Nagpal
FJFatimah Jan
Fatimah Jan
UHUditi Handa
Uditi Handa
PKPriyanka Kriplani
Priyanka Kriplani
RDRameshwar Dass
Rameshwar Dass
SDSheetal Devi
Sheetal Devi
The purpose of the current research was to prepare a delayed-release system of mini-tablets (gastroprokinetic drug). The model drug (itopride hydrochloride) was formulated with the combination of methylcellulose (free-flowing agent) and Eudragit® S-100 (enteric coating agent) for delayed release. The research objective was to control the drug release in the stomach. The preparation of floating minitablets in three batches using different concentrations of polymers (methylcellulose in increasing order and Eudragit® S-100 remaining constant in two batches and the concentration decreased in the third batch) was utilized for the maintenance of the drug release pattern by evaluating the three batches for their weight variation, content uniformity, % drug release, thickness, hardness and friability tests. The selection of optimized formulation was based on the in vitro dissolution studies and floating lag time. As a result, Eudragit® S-100 showed a better-delayed release action. Formulation F2 gave better-delayed release (67.09 % for 360 minutes) and floating properties (1.34 minutes for lag time) in comparison to other batches i.e.; F1 and F3. The F3 results showed that the floating lag time (1.29 minutes) will decline, while methylcellulose concentration increases but Eudragit® S-100 concentration decreases, which reveals the enteric coating action of the Eudragit® S-100 polymer for delayed drug release in the studies.

26 June 2024
Verified
Book Chapter
Closed access
PDF file
KNKajal Nagpal
Kajal Nagpal
UHUditi Handa
Uditi Handa
ADAbhilasha Dubey
Abhilasha Dubey
AIAkshara Rushikesh Indulkar
Akshara Rushikesh Indulkar